Periodic Reporting for period 2 - FIDA (Scale-up of our disruptive antibody analytical platform based in flow-induced dispersion analysis (FIDA) to increase efficiency in the research of new antibodies and vaccines)

In the last decades, a growing emphasis has been on finding effective therapeutic products against major diseases within oncology, CNS, immunology etc. outside the realm of traditional small molecules. In 2017, just monoclonal antibodies had total sales worth €83.8bn. In the...